| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/26/2006 | US7112424 Generation of protein hydrolysate from soy flour; obtain soy flour, generate slurry, hydrolyze, deactivate enzymes, separate solids, recover protein hydrolysate |
| 09/26/2006 | US7112421 Nucleic acids encoding BAFF receptor, chimeric proteins and methods and compositions related thereto |
| 09/26/2006 | US7112419 For suppression of hepatocellular carcinoma; genetic engineering |
| 09/26/2006 | US7112418 Ion channel |
| 09/26/2006 | US7112412 Binding to prostate specific membrane antigen (PSMA) with a radioactive monoclonal antibody or Fab fragments; detecting and kill the cancer cells; bioassay; radiotherapy |
| 09/26/2006 | US7112324 CD 19×CD3 specific polypeptides and uses thereof |
| 09/26/2006 | US7112317 Administering a targeting agent operatively attached to a therapeutic agent; the targeting agent recognizes and binds to a tumor-associated endothelial cell marker. |
| 09/26/2006 | CA2283464C Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 09/21/2006 | WO2006099592A2 Mannose immunogens for hiv-1 |
| 09/21/2006 | WO2006099480A2 Stress proteins and peptides and methods of use thereof |
| 09/21/2006 | WO2006099101A1 Immunogenic compositions for mucosal delivery |
| 09/21/2006 | WO2006099006A2 Recombinant e-selectin made in insect cells |
| 09/21/2006 | WO2006098793A2 Hslim modulates immune responses |
| 09/21/2006 | WO2006098465A1 Prophylactic/therapeutic agent for cancer |
| 09/21/2006 | WO2006097708A2 Affinity purification of protein |
| 09/21/2006 | WO2006058300A3 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 |
| 09/21/2006 | WO2005001057A3 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 09/21/2006 | WO2004089282A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/21/2006 | US20060211848 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses |
| 09/21/2006 | US20060211846 Zinc finger binding domains for nucleotide sequence ANN |
| 09/21/2006 | US20060211622 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 09/21/2006 | US20060211620 Nucleic acid constructs, recombinant expression vectors, and recombinant host cells comprising the polynucleotides |
| 09/21/2006 | US20060211618 Polynucleotides and polypeptides of the erythropoietin gene |
| 09/21/2006 | US20060211150 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211149 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211148 Protein biopolymer markers indicative of age matched control |
| 09/21/2006 | US20060211147 Protein biopolymer markers indicative of age matched control |
| 09/21/2006 | US20060211144 Protein biopolymer markers indicative of age matched control |
| 09/21/2006 | US20060211143 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211142 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211118 Induced by fermentable glucose or non-fermentable ethanol |
| 09/21/2006 | US20060211107 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 09/21/2006 | US20060211094 Glucose dehydrogenase beta subunit and DNA encoding the same |
| 09/21/2006 | US20060211093 Membrane scaffold proteins and embedded membrane proteins |
| 09/21/2006 | US20060211092 Membrane scaffold proteins and tethered membrane proteins |
| 09/21/2006 | US20060211091 MAGE-A3 peptides presented by HLA class II molecules |
| 09/21/2006 | US20060211090 Human cDNAs and proteins and uses thereof |
| 09/21/2006 | US20060211089 Expression of defensins in filamentous fungi |
| 09/21/2006 | US20060211088 Method for generating variable domain sequences of heavy chain antibodies |
| 09/21/2006 | US20060211087 Compositions and methods for producing recombinant proteins |
| 09/21/2006 | US20060211086 Process for manufacture of nematode-extracted anticoagulant protein (NAP) |
| 09/21/2006 | US20060211085 disruption of the newly isolated P. pastoris AMR2 gene encoding beta 1,2-mannosyltransferase |
| 09/21/2006 | US20060211084 Simplified eukaryotic nitrate reductase |
| 09/21/2006 | US20060211083 Products and processes for in vitro synthesis of biomolecules |
| 09/21/2006 | US20060211058 Diagnosis and treatment of malignant neoplasms |
| 09/21/2006 | US20060211056 Leishmania antigens suitable for a diagnostic kit of Leishmania |
| 09/21/2006 | US20060211053 Selecting therapeutic human monoclonal antibodies for disease-specific libraries |
| 09/21/2006 | US20060211052 Screening antibodies using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 09/21/2006 | US20060211051 Methods and reagents for preparing and using immunological agents specific for p-glycoprotein |
| 09/21/2006 | US20060211050 Methods of using 18903 to treat pain and pain-related disorders |
| 09/21/2006 | US20060211046 Bacterial ligand-binding sensor |
| 09/21/2006 | US20060211043 Ability to bind to an insect molting hormone such as ecdysteroid; used as insect growth inhibitor is effective for the development of a disinfestant |
| 09/21/2006 | US20060211033 Novel gene |
| 09/21/2006 | US20060211031 Novel proteins and nucleic acids encoding same |
| 09/21/2006 | US20060211013 Method for sorting antifungal molecules acting on the glucanosyltransferase activity |
| 09/21/2006 | US20060210991 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/21/2006 | US20060210978 Proteome-wide mapping of post-translational modifications using endopeptidases |
| 09/21/2006 | US20060210971 Pectate lyases, nucleic encoding them and methods for making and using them |
| 09/21/2006 | US20060210587 Virus-like particles for the induction of autoantibodies |
| 09/21/2006 | US20060210583 Nucleic acids encoding Sarcocystis neurona antigen and uses thereof |
| 09/21/2006 | US20060210582 Nucleic acids and proteins from streptococcus groups A & B |
| 09/21/2006 | US20060210581 Nucleic acids and proteins from streptococcus groups A & B |
| 09/21/2006 | US20060210580 Nucleic acids and proteins from streptococcus groups A & B |
| 09/21/2006 | US20060210579 Nucleic acids and proteins from streptococcus groups A & B |
| 09/21/2006 | US20060210578 Immunogenic polypeptide isolated from mycobacterium avium subspecies paratuberculosis and uses therof |
| 09/21/2006 | US20060210577 isolated nucleic acid molecule encoding polypeptide as antitumor biodrugs; monoclonal antibody; modulation of chemokine, cytokine expression; transfected host cell; anticarcinogenic agents |
| 09/21/2006 | US20060210575 Cytotoxic protein and utilization thereof |
| 09/21/2006 | US20060210571 Engineering antibodies that bind irreversibly |
| 09/21/2006 | US20060210567 Antibodies against pd-1 and uses therefor |
| 09/21/2006 | US20060210564 Novel diabody-type bispecific antibody |
| 09/21/2006 | US20060210560 TNF receptor action modulaton |
| 09/21/2006 | US20060210559 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 09/21/2006 | US20060210556 Novel composition and methods for the treatment of immune disorders |
| 09/21/2006 | US20060210539 Activating expression of an endogenous Pigment Epithelium Derived Factor gene in one or more cells of an organism; ocular neovascularization in an organism |
| 09/21/2006 | US20060210510 Isolated polypeptide with glycosyl transferase enzymatic activity for producing dextrans with alpha (1 --> 2) sidechains, comprising at least one region for bonding to glucan and a catalytically active region situated beyond the region bonding to glucan; expression vectors; genetic engineering |
| 09/21/2006 | US20060210473 VEGF-conjugate combined methods for tumor vasculature targeting and tumor treatment |
| 09/21/2006 | CA2734043A1 Skin equivalent culture |
| 09/21/2006 | CA2601797A1 Mannose immunogens for hiv-1 |
| 09/21/2006 | CA2601255A1 Hslim modulates immune responses |
| 09/21/2006 | CA2600844A1 Macromolecules comprising a thioether cross-link |
| 09/21/2006 | CA2600690A1 Recombinant e-selectin made in insect cells |
| 09/21/2006 | CA2600568A1 Prophylactic/therapeutic agent for cancer |
| 09/21/2006 | CA2600505A1 Anti-mesothelin antibodies |
| 09/21/2006 | CA2578908A1 Expression vectors for enhanced transient gene expression and mammalian cells expressing them |
| 09/20/2006 | EP1702984A2 A method for detecting prostate cancer |
| 09/20/2006 | EP1702928A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2006 | EP1702624A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 09/20/2006 | EP1702620A1 Immunopotentiator and method of enhancing immunological activity with the same |
| 09/20/2006 | EP1702074A2 Prevention of incorporation of non-standard amino acids into protein |
| 09/20/2006 | EP1701772A2 Biomolecule partition motifs and uses thereof |
| 09/20/2006 | EP1444363B1 Transfection kinetics and structural promoters |
| 09/20/2006 | EP1303530B1 CLONING AND PRODUCING THE N. i Bst /i NBI NICKING ENDONUCLEASE AND RELATED METHODS FOR USING NICKING ENDONUCLEASES IN SINGLE-STRANDED DISPLACEMENT AMPLIFICATION |
| 09/20/2006 | EP1280897B1 Regulation of nf-at interacting protein nip 45 variant |
| 09/20/2006 | EP1246841B1 Transcription factors containing two potential dna binding motifs |
| 09/20/2006 | EP0912718B1 Method for protein stabilisation of wines |
| 09/20/2006 | EP0774004B1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 09/20/2006 | CN1836038A Methods for producing secreted polypeptides |
| 09/20/2006 | CN1836033A Use of oxalate deficient Aspergillus Niger strains for producing a polypeptide |
| 09/20/2006 | CN1835969A Mechanism of conditional regulation of hypoxia-inducible factor-1 by von Hippel-Lindau tumor suppressor protein |
| 09/20/2006 | CN1835679A Process for producing human-origin immunocompetent cell |